Pulmonx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pulmonx and other ETFs, options, and stocks.About LUNG
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the United States, Europe, Middle East, Africa, Asia Pacific, and Other International segments.
CEOGlendon E. French
CEOGlendon E. French
Employees291
Employees291
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1995
Founded1995
Employees291
Employees291
LUNG Key Statistics
Market cap93.63M
Market cap93.63M
Price-Earnings ratio-1.57
Price-Earnings ratio-1.57
Dividend yield—
Dividend yield—
Average volume1.03M
Average volume1.03M
High today$2.28
High today$2.28
Low today$2.19
Low today$2.19
Open price$2.22
Open price$2.22
Volume172.40K
Volume172.40K
52 Week high$9.37
52 Week high$9.37
52 Week low$1.31
52 Week low$1.31
Stock Snapshot
With a market cap of 93.63M, Pulmonx(LUNG) trades at $2.28. The stock has a price-to-earnings ratio of -1.57.
As of 2025-12-24, Pulmonx(LUNG) stock has fluctuated between $2.19 and $2.28. The current price stands at $2.28, placing the stock +4.1% above today's low and 0.0% off the high.
Pulmonx(LUNG) shares are trading with a volume of 172.4K, against a daily average of 1.03M.
In the last year, Pulmonx(LUNG) shares hit a 52-week high of $9.37 and a 52-week low of $1.31.
In the last year, Pulmonx(LUNG) shares hit a 52-week high of $9.37 and a 52-week low of $1.31.
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own LUNG. This list is generated using Robinhood data, and it’s not a recommendation.